INSERM UMR1163, Laboratory of Intestinal Immunity, Institut Imagine, 75015 Paris, France; Université Paris Descartes-Sorbonne Paris Cité and Institut Imagine, 75015 Paris, France.
INSERM UMR1163, Laboratory of Intestinal Immunity, Institut Imagine, 75015 Paris, France; Université Paris Descartes-Sorbonne Paris Cité and Institut Imagine, 75015 Paris, France; AP-HP, Department of Gastroenterology, Hôpital Européen Georges Pompidou, 75015 Paris, France.
Immunity. 2016 Sep 20;45(3):610-625. doi: 10.1016/j.immuni.2016.07.018. Epub 2016 Sep 6.
The nature of gut intraepithelial lymphocytes (IELs) lacking antigen receptors remains controversial. Herein we showed that, in humans and in mice, innate intestinal IELs expressing intracellular CD3 (iCD3(+)) differentiate along an Id2 transcription factor (TF)-independent pathway in response to TF NOTCH1, interleukin-15 (IL-15), and Granzyme B signals. In NOTCH1-activated human hematopoietic precursors, IL-15 induced Granzyme B, which cleaved NOTCH1 into a peptide lacking transcriptional activity. As a result, NOTCH1 target genes indispensable for T cell differentiation were silenced and precursors were reprogrammed into innate cells with T cell marks including intracellular CD3 and T cell rearrangements. In the intraepithelial lymphoma complicating celiac disease, iCD3(+) innate IELs acquired gain-of-function mutations in Janus kinase 1 or Signal transducer and activator of transcription 3, which enhanced their response to IL-15. Overall we characterized gut T cell-like innate IELs, deciphered their pathway of differentiation and showed their malignant transformation in celiac disease.
肠道上皮内淋巴细胞(IEL)缺乏抗原受体的本质仍存在争议。本文中,我们发现,在人类和小鼠中,表达细胞内 CD3(iCD3(+))的固有肠道 IEL 可响应 TF NOTCH1、白细胞介素-15(IL-15)和颗粒酶 B 信号沿 Id2 转录因子(TF)独立途径分化。在 NOTCH1 激活的人类造血前体中,IL-15 诱导颗粒酶 B,后者将 NOTCH1 切割成缺乏转录活性的肽。结果,NOTCH1 靶基因对 T 细胞分化必不可少,被沉默,前体被重新编程为具有 T 细胞标记的固有细胞,包括细胞内 CD3 和 T 细胞重排。在合并乳糜泻的肠内淋巴瘤中,iCD3(+)固有 IEL 获得了 Janus 激酶 1 或信号转导和转录激活因子 3 的功能获得性突变,增强了它们对 IL-15 的反应。总体而言,我们对肠道 T 细胞样固有 IEL 进行了特征描述,阐明了它们的分化途径,并显示了它们在乳糜泻中的恶性转化。